|
Kunwar Shailubhai Ph.D. has served as Senior Vice President Drug Discovery of Synergy Pharmaceuticals Inc. since March 2004. From May 2003 until March 2004 Dr. Shailubhai served as Executive Vice President Research and Development. From 2001 to April 2003 Dr. Shailubhai held the position of Vice President Drug Discovery at Synergy Pharmaceuticals Inc where he was chiefly responsible for the development of Synergy's GCRA agonsit program for drugs to treat colon cancer and GI inflammation. Between 1993 and 2000 he was affiliated with Monsanto Company as Group Leader of the cancer chemoprevention group during which time he worked on a number of cancer research projects including inhibitors of metalloproteinases 5-lipoxygenase and cyclooxygenase-2. Dr. Shailubhai previously served as a Senior Staff Fellow at the National Institutes of Health and as an Assistant Professor at the University of Maryland. Dr. Shailubhai received his Ph.D. in microbiology in 1984 from the University of Baroda India and his M.B. A. in 2001 from the University of Missouri St. Louis. | 